Advertisement

The Scientist

» leukemia

Most Recent

image: IDing Cancer with 3-D Genomics

IDing Cancer with 3-D Genomics

By | May 7, 2014

In a proof-of-principle study, scientists show that the three-dimensional shape of a cancer cell genome can reliably classify subtypes of human leukemia.

0 Comments

image: Commander of an Immune Flotilla

Commander of an Immune Flotilla

By | April 1, 2014

With much of his early career dictated by US Navy interests, Carl June drew inspiration from malaria, bone marrow transplantation, and HIV in his roundabout path to a breakthrough in cancer immunotherapy.

1 Comment

image: Tumor-Targeting T Cells Engineered

Tumor-Targeting T Cells Engineered

By | August 11, 2013

Scientists genetically modify T cells derived from pluripotent stem cells to attack lymphatic tumors.

0 Comments

image: Chemotherapy Pioneer Dies

Chemotherapy Pioneer Dies

By | May 6, 2013

Emil Frei III, a cancer researcher who in the 1950s combined multiple chemotherapy drugs to treat childhood leukemia, has died at the age of 89.

0 Comments

image: Leukemia Linked to Changes in Womb

Leukemia Linked to Changes in Womb

By | April 10, 2013

Genetic changes that may initiate childhood leukemia could originate while the baby is still in utero.

0 Comments

image: Immune System Kills Cancer

Immune System Kills Cancer

By | March 27, 2013

T-cells engineered to attack B-cells sent adults’ acute leukemia into remission.

11 Comments

image: Little Cancer Risk from Fukushima

Little Cancer Risk from Fukushima

By | March 1, 2013

A new report from the World Health Organization predicts only very minimal increases in cancer risk for residents in the vicinity of the nuclear disaster.

0 Comments

image: Ancient Viruses Wreak New Havoc

Ancient Viruses Wreak New Havoc

By | October 24, 2012

Viral DNA in mice genomes may lead to cancer in immune-compromised animals.

0 Comments

image: CT Scans Increase Risk of Cancer

CT Scans Increase Risk of Cancer

By | June 7, 2012

Exposure to doses of radiation used in some diagnostics in childhood can triple the risk of brain cancer and leukemia as an adult.

1 Comment

image: Designing Transition-State Inhibitors

Designing Transition-State Inhibitors

By | May 1, 2012

A transition-state mimic has the power to bind an enzyme at its tipping point as strongly as any available inhibitor and more strongly than most, preventing enzymatic activity. 

1 Comment

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Teknova
Teknova
Advertisement
Life Technologies